By Michele Maatouk
Date: Tuesday 16 May 2023
(Sharecast News) - Horizon Therapeutics tumbled in pre-market trade on Tuesday following a report that its $27.8bn takeover by Amgen will be challenged by federal regulators.
By Michele Maatouk
Date: Monday 12 Dec 2022
(Sharecast News) - California-based biopharmaceutical group Amgen has agreed to buy Horizon Therapeutics in a $28.3bn deal.
By Abigail Townsend
Date: Tuesday 27 Sep 2022
(Sharecast News) - AstraZeneca drug Tezspire has been approved for use with patients with severe asthma in Japan, the blue chip confirmed on Tuesday.
Currency | US Dollars |
Share Price | $ 288.18 |
Change Today | $ 4.64 |
% Change | 1.64 % |
52 Week High | $339.19 |
52 Week Low | $258.59 |
Volume | 5,439,225 |
Shares Issued | 536.90m |
Market Cap | $154,724m |
RiskGrade | 100 |
Strong Buy | 6 |
Buy | 6 |
Neutral | 15 |
Sell | 2 |
Strong Sell | 1 |
Total | 30 |
Time | Volume / Share Price |
16:00 | 200 @ $287.80 |
16:00 | 147 @ $287.81 |
16:00 | 1,638 @ $287.81 |
16:00 | 2,500 @ $287.81 |
16:00 | 200 @ $287.82 |
You are here: research